Literature DB >> 17589976

Early cardioprotective effect of sevoflurane on left ventricular performance during coronary artery bypass grafting on a beating heart: randomized controlled study.

Ino Huseidzinović1, Stjepan Barisin, Nikola Bradić, Rudolf Milanović.   

Abstract

AIM: To evaluate the cardioprotective effect of sevoflurane on a beating heart in patients undergoing coronary artery bypass grafting with normal preoperative left ventricular function.
METHODS: The randomized controlled study included 32 patients induced with sevoflurane and then randomized to receive either 1 minimal alveolar concentration (MAC) end-tidal concentration of sevoflurane (n=16) or propofol (n=16) 2 to 3 mg kg(-1) hour(-1). The acceleration of the aortic blood flow, cardiac index, heart rate, mean arterial pressure, and central venous pressure were measured 5 minutes after anesthesia induction, at the beginning of ischemia, 15 minutes after ischemia, and 15 minutes after sternum closure.
RESULTS: There were no differences in heart rate, mean arterial pressure, and central venous pressure within each group and between groups during surgery. Acceleration increased in the sevoflurane group 15 minutes after ischemia (10.3+/-3.5 m/s(2); P=0.004) and 15 minutes after sternum closure (10.7+/-3.9 m/s(2); P<0.001). Acceleration in the propofol group decreased from the beginning of ischemia (P<0.001) and remained lower 15 minutes after sternum closure (P=0.001 and P=0.024, respectively). Acceleration was higher in the sevoflurane group at the beginning of ischemia and 15 minutes after sternum closure (P=0.017 and P=0.046, respectively). There were no significant differences in cardiac index values within the sevoflurane group. In the propofol group, significant decreases in cardiac index were seen at the beginning of ischemia (P<0.001). There were between-group differences in cardiac index values at the beginning of ischemia and 15 minutes after ischemia (P=0.002, and P=0.011, respectively).
CONCLUSION: Cardiac function was better preserved in the patients anesthetized with sevoflurane than in patients anesthetized with propofol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589976      PMCID: PMC2080533     

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  17 in total

1.  Catheter replacement of the needle in percutaneous arteriography; a new technique.

Authors:  S I SELDINGER
Journal:  Acta radiol       Date:  1953-05       Impact factor: 1.990

2.  Protein tyrosine kinase-dependent modulation of isoflurane effects on cardiac sarcolemmal K(ATP) channel.

Authors:  Anna Stadnicka; Wai-Meng Kwok; David C Warltier; Zeljko J Bosnjak
Journal:  Anesthesiology       Date:  2002-11       Impact factor: 7.892

Review 3.  Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2.

Authors:  R A Kloner; R B Jennings
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

Review 4.  Clinical evidence for stunned myocardium after coronary artery bypass surgery.

Authors:  R A Kloner; K Przyklenk; G L Kay
Journal:  J Card Surg       Date:  1994-05       Impact factor: 1.620

5.  One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo.

Authors:  D Obal; B Preckel; H Scharbatke; J Müllenheim; F Höterkes; V Thämer; W Schlack
Journal:  Br J Anaesth       Date:  2001-12       Impact factor: 9.166

6.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

7.  Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration.

Authors:  Stefan G De Hert; Philippe J Van der Linden; Stefanie Cromheecke; Roel Meeus; Anne Nelis; Veronique Van Reeth; Pieter W ten Broecke; Ivo G De Blier; Bernard A Stockman; Inez E Rodrigus
Journal:  Anesthesiology       Date:  2004-08       Impact factor: 7.892

8.  A prospective, randomised, single-blind pilot study to determine the effect of anaesthetic technique on troponin T release after off-pump coronary artery surgery.

Authors:  J B Kendall; G N Russell; N D A Scawn; M Akrofi; C M Cowan; M A Fox
Journal:  Anaesthesia       Date:  2004-06       Impact factor: 6.955

9.  Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery.

Authors:  Peter F Conzen; Susanne Fischer; Christian Detter; Klaus Peter
Journal:  Anesthesiology       Date:  2003-10       Impact factor: 7.892

10.  Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass.

Authors:  Stefan G De Hert; Philippe J Van der Linden; Stefanie Cromheecke; Roel Meeus; Pieter W ten Broecke; Ivo G De Blier; Bernard A Stockman; Inez E Rodrigus
Journal:  Anesthesiology       Date:  2004-07       Impact factor: 7.892

View more
  6 in total

1.  Sevoflurane alleviates myocardial ischemia/reperfusion injury via actitation of heat shock protein-70 in patients undergoing double valve replacement surgery.

Authors:  Yue Shan; Kai Xie; Qifu Zhou; Rui He; Zhonghua Chen; Weizhong Feng
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  Methodological Errors in Clinical Studies Published by Medical Journals of Ex-Yugoslav Countries.

Authors:  Slobodan M Jankovic; Izet Masic
Journal:  Acta Inform Med       Date:  2020-06

3.  Cardioprotective effect of sevoflurane in patients with coronary artery disease undergoing vascular surgery.

Authors:  Ahmed S Bassuoni; Yasser M Amr
Journal:  Saudi J Anaesth       Date:  2012-04

Review 4.  Myocardial conditioning techniques in off-pump coronary artery bypass grafting.

Authors:  Marco Moscarelli; Prakash P Punjabi; Gamov I Miroslav; Paolo Del Sarto; Francesca Fiorentino; Gianni D Angelini
Journal:  J Cardiothorac Surg       Date:  2015-01-20       Impact factor: 1.637

5.  Sevoflurane postconditioning protects the myocardium against ischemia/reperfusion injury via activation of the JAK2-STAT3 pathway.

Authors:  Jianjiang Wu; Jin Yu; Peng Xie; Yiliyaer Maimaitili; Jiang Wang; Long Yang; Haiping Ma; Xing Zhang; Yining Yang; Hong Zheng
Journal:  PeerJ       Date:  2017-04-04       Impact factor: 2.984

6.  Sevoflurane inhibits cardiac function in pulmonary fibrosis mice through the TLR4 signaling pathway.

Authors:  Yanan Cao; Zhenghua He; Maoen Zhu; Xiaowei Gao; Yue Yang; Junjie Zhang; Yundan Pan; Qulian Guo; Yonggang Peng; E Wang
Journal:  Pulm Circ       Date:  2018-08-30       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.